The Tilorone, with the CAS registry number 27591-97-5, has the systematic name of 2,7-bis[2-(diethylamino)ethoxy]-9H-fluoren-9-one. And the molecular formula of the chemical is C25H34N2O3.
The characteristics of this chemical are as followings: (1)ACD/LogP: 5.25; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 1.15; (4)ACD/LogD (pH 7.4): 1.58; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1.24; (7)ACD/KOC (pH 5.5): 1.36; (8)ACD/KOC (pH 7.4): 3.67; (9)#H bond acceptors: 5; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 12; (12)Polar Surface Area: 42.01 Å2; (13)Index of Refraction: 1.563; (14)Molar Refractivity: 121.05 cm3; (15)Molar Volume: 372.4 cm3; (16)Polarizability: 47.98×10-24cm3; (17)Surface Tension: 44.1 dyne/cm; (18)Density: 1.102 g/cm3; (19)Flash Point: 287.8 °C; (20)Enthalpy of Vaporization: 83.28 kJ/mol; (21)Boiling Point: 552.3 °C at 760 mmHg; (22)Vapour Pressure: 3.05E-12 mmHg at 25°C.
Addtionally, the following datas could be converted into the molecular structure:
(1)SMILES: O=C3c1cc(OCCN(CC)CC)ccc1c2c3cc(OCCN(CC)CC)cc2
(2)InChI: InChI=1/C25H34N2O3/c1-5-26(6-2)13-15-29-19-9-11-21-22-12-10-20(30-16-14-27(7-3)8-4)18-24(22)25(28)23(21)17-19/h9-12,17-18H,5-8,13-16H2,1-4H3
(3)InChIKey: MPMFCABZENCRHV-UHFFFAOYAH
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 121mg/kg (121mg/kg) | Toxicology and Applied Pharmacology. Vol. 23, Pg. 102, 1972. | |
mouse | LD50 | oral | 1780mg/kg (1780mg/kg) | Pharmaceutical Chemistry Journal Vol. 23, Pg. 497, 1989. | |
mouse | LD50 | unreported | 200mg/kg (200mg/kg) | IMMUNOLOGICAL INCLUDING ALLERGIC: INCREASED IMMUNE RESPONSE | Pharmaceutical Chemistry Journal Vol. 12, Pg. 1460, 1978. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View